The rounds this investor is named on, who it invests beside, and where it shows up.
Named on 8 rounds in the feed, most often at Series D+ and in Biotech.
premjiinvest.comRounds from 2022-06-09 to 2026-09-24
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
BigHat Biosciences, Inc. A clinical-stage, AI-driven protein therapeutics platform company | Series C Verified against 19 sources | $75M | 2026-09-24 | [ LEAD ] |
Enveda Biosciences A clinical-stage biotechnology company that uses AI to discover medicines from life's chemistry | Series E ext. |
| $311M |
| 2026-09-23 |
| [ PART ] |
Ultrahuman Ultrahuman sells health tracking devices and services, including continuous glucose monitors and performance analytics, primarily for health-conscious consumers. | Series C Published on thinner evidence, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $42.9M | 2026-03-19 | [ LEAD ] |
Enveda Biosciences A clinical-stage biotechnology company that uses AI to discover medicines from life's chemistry | Series D Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $150M | 2025-09-04 | [ LEAD ] |
Enveda Biosciences A clinical-stage biotechnology company that uses AI to discover medicines from life's chemistry | Series C Published on thinner evidence, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $130M | 2024-11-21 | [ PART ] |
Purplle An online platform that touches more than 10 million consumers every month | Series F Published on thinner evidence, 2 sources | $158.7M | 2024-10-14 | [ PART ] |
Enveda Biosciences A clinical-stage biotechnology company that uses AI to discover medicines from life's chemistry | Series B Published on thinner evidence, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $55M | 2024-06-14 | [ PART ] |
Purplle An online platform that touches more than 10 million consumers every month | Series E Published on thinner evidence, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $33M | 2022-06-09 | [ PART ] |